Cargando…
Review of the safety, efficacy, costs and patient acceptability of recombinant follicle-stimulating hormone for injection in assisting ovulation induction in infertile women
Anovulation is a common cause of female subfertility. Treatment of anovulation is aimed at induction of ovulation. In women with clomiphene-citrate resistant WHO group II anovulation, one of the treatment options is ovulation induction with exogenous follicle-stimulating hormone (FSH or follitropin)...
Autores principales: | Nahuis, Marleen, van der Veen, Fulco, Oosterhuis, Jur, Mol, Ben Willem, Hompes, Peter, van Wely, Madelon |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2971716/ https://www.ncbi.nlm.nih.gov/pubmed/21072289 |
Ejemplares similares
-
Women’s perspectives on ovulation induction with or without IUI as treatment for normogonadotrophic anovulation: a discrete choice experiment
por: Weiss, N S, et al.
Publicado: (2017) -
The M-OVIN study: does switching treatment to FSH and / or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate – a randomised controlled trial
por: Nahuis, Marleen J, et al.
Publicado: (2013) -
The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment?
por: Gleicher, Norbert, et al.
Publicado: (2011) -
The INeS study: prevention of multiple pregnancies: a randomised controlled trial comparing IUI COH versus IVF e SET versus MNC IVF in couples with unexplained or mild male subfertility
por: Bensdorp, Alexandra J, et al.
Publicado: (2009) -
Phase IV, open-label, randomized study of low-dose recombinant human follicle-stimulating hormone protocols for ovulation induction
por: Serour, Gamal I, et al.
Publicado: (2014)